ATE350061T1 - Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält - Google Patents

Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält

Info

Publication number
ATE350061T1
ATE350061T1 AT00955850T AT00955850T ATE350061T1 AT E350061 T1 ATE350061 T1 AT E350061T1 AT 00955850 T AT00955850 T AT 00955850T AT 00955850 T AT00955850 T AT 00955850T AT E350061 T1 ATE350061 T1 AT E350061T1
Authority
AT
Austria
Prior art keywords
quinoline
treatment
composition
calcium channel
channel blocker
Prior art date
Application number
AT00955850T
Other languages
English (en)
Inventor
Robert H Keller
Original Assignee
Phoenix Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenix Biosciences Inc filed Critical Phoenix Biosciences Inc
Application granted granted Critical
Publication of ATE350061T1 publication Critical patent/ATE350061T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00955850T 1999-08-23 2000-08-23 Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält ATE350061T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15026199P 1999-08-23 1999-08-23

Publications (1)

Publication Number Publication Date
ATE350061T1 true ATE350061T1 (de) 2007-01-15

Family

ID=22533745

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00955850T ATE350061T1 (de) 1999-08-23 2000-08-23 Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält

Country Status (7)

Country Link
EP (1) EP1210116B1 (de)
CN (2) CN1994466A (de)
AP (1) AP1691A (de)
AT (1) ATE350061T1 (de)
AU (1) AU775903B2 (de)
DE (1) DE60032777T2 (de)
WO (1) WO2001013907A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7479498B2 (en) * 1999-08-23 2009-01-20 Phoenix Biosciences, Inc. Treatments for viral infections
CN1319531C (zh) * 2005-06-08 2007-06-06 复旦大学 喹啉类生物碱在制备抗乙肝病毒药物中的用途
US8889743B2 (en) * 2007-06-20 2014-11-18 Board Of Regents, University Of Texas System Inhibition of filovirus entry into cells and uses thereof
CN104203228A (zh) * 2012-03-30 2014-12-10 马来亚大学 具有抗黄病毒的抗病毒活性的组合物
US10842776B2 (en) 2016-06-28 2020-11-24 Assistance Publique—Hopitaua de Paris Hycanthone derivatives and Primaquine derivatives for use in the prevention and/or the treatment of disorders associated to gammaherpesvirus
CN109820852B (zh) * 2019-03-11 2021-02-19 中国农业科学院兰州兽医研究所 一种尼莫地平在制备预防口蹄疫病毒感染的药物中的应用
FR3109723A1 (fr) * 2020-05-04 2021-11-05 Dyna + Composition de renforcement et/ou de régulation de la réponse immunitaire
EP4658277A1 (de) * 2023-01-31 2025-12-10 Griffith University Verfahren zur behandlung von virusinfektionen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897403A (en) * 1986-11-18 1990-01-30 The United States Of America As Represented By The Secretary Of The Army Antimalarial compositions and methods
US5278173A (en) * 1988-06-30 1994-01-11 Davis Michael H Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo
US5430039A (en) * 1990-09-28 1995-07-04 Cephalon, Inc. Treatment of neurological disorders

Also Published As

Publication number Publication date
AU775903B2 (en) 2004-08-19
AU6798800A (en) 2001-03-19
DE60032777D1 (de) 2007-02-15
CN1297317C (zh) 2007-01-31
CN1399558A (zh) 2003-02-26
WO2001013907A3 (en) 2001-08-30
WO2001013907A2 (en) 2001-03-01
CN1994466A (zh) 2007-07-11
AP1691A (en) 2006-12-11
DE60032777T2 (de) 2007-11-08
AP2002002432A0 (en) 2002-03-31
EP1210116B1 (de) 2007-01-03
EP1210116A2 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
ATE501732T1 (de) Antibiotische zusammensetzung, die moxifloxacin enthält, zur behandlung von augen
ATE494884T1 (de) Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69528109D1 (de) Thieno -1,5- benzodiazepin zur Behandlung gastrointestinaler Beschwerden
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE376994T1 (de) Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60137631D1 (de) Ireovirus antikörpern zur behandlung von ras-vermittelten, proliferativen erkrankungen
DE60030554D1 (de) Verwendungen von et743 zur behandlung von krebs
DE60136477D1 (de) Retinoide zur behandlung von emphysem
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60112581D1 (de) Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten
DE60032777D1 (de) Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
ATE528004T1 (de) Chinolon-antibiotika zur behandlung von periodontaler infektionen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties